Gemfibrozil
CAS 25812-30-0 3 FDA-DMF suppliersSmall Molecule
Overview
Gemfibrozil is an antihyperlipidemic agent that reduces cholesterol and triglyceride levels in the blood with a particular effect on reducing triglycerides and raising HDL cholesterol. It is primarily used to treat dyslipidemia and prevent cardiovascular disease.
Therapeutic areas
CardiovascularMetabolic
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.